Profil
James D.
Laur is currently Director at Prometheus Laboratories, Inc. since 2020, Director at Gemelli Biotech Corp., and Chief Intellectual Property Officer & MD at Cedars-Sinai Technology Ventures (Venture Capital) since 2021.
Former positions include Director at Prometheus Biosciences, Inc. from 2020 to 2023 and Member of the California State Bar Association.
Education includes an undergraduate degree from the University of California, Los Angeles in 1983 and a graduate degree from Boston College Law School in 1986.
Aktive Positionen von James Laur
| Unternehmen | Position | Beginn |
|---|---|---|
Gemelli Biotech Corp.
Gemelli Biotech Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Direktor/Vorstandsmitglied | 01.04.2020 |
The Cedars-Sinai Accelerator
The Cedars-Sinai Accelerator Investment ManagersFinance Cedars-Sinai invests in companies located in the United States. The firm focuses on the healthcare. It participates in seed and early stage capital requirements with an investment size of USD 0.50 - 5 million. The firm makes follow-on investments. | Private Equity Investor | 01.07.2021 |
Ehemalige bekannte Positionen von James Laur
| Unternehmen | Position | Ende |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 16.06.2023 |
California State Bar Association | Corporate Officer/Principal | - |
Ausbildung von James Laur
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
California State Bar Association | |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Gemelli Biotech Corp.
Gemelli Biotech Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
The Cedars-Sinai Accelerator
The Cedars-Sinai Accelerator Investment ManagersFinance Cedars-Sinai invests in companies located in the United States. The firm focuses on the healthcare. It participates in seed and early stage capital requirements with an investment size of USD 0.50 - 5 million. The firm makes follow-on investments. | Finance |
















